These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 1354041

  • 21. Some cardiovascular effects of monoamine oxidase inhibitors in unanaesthetized rats.
    Marwood JF, Huston V, Wall KT.
    Clin Exp Pharmacol Physiol; 1985; 12(2):161-8. PubMed ID: 3839173
    [Abstract] [Full Text] [Related]

  • 22. Effects of gestational exposure to monoamine oxidase inhibitors in rats: preliminary behavioral and neurochemical studies.
    Whitaker-Azmitia PM, Zhang X, Clarke C.
    Neuropsychopharmacology; 1994 Oct; 11(2):125-32. PubMed ID: 7840864
    [Abstract] [Full Text] [Related]

  • 23. The novel neuropsychotropic agent milacemide is a specific enzyme-activated inhibitor of brain monoamine oxidase B.
    Janssens de Varebeke P, Pauwels G, Buyse C, David-Remacle M, De Mey J, Roba J, Youdim MB.
    J Neurochem; 1989 Oct; 53(4):1109-16. PubMed ID: 2769256
    [Abstract] [Full Text] [Related]

  • 24. Microsomal enzymes and potentiation of tyramine pressor response.
    Renton KW, Eade NR.
    Biochem Pharmacol; 1972 May 15; 21(10):1393-402. PubMed ID: 5029421
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Effect of tyramine and cheese on the blood pressure and their modification by DL-serine-N2-isopropylhydrazide (Ro 4-1038) on awake intact dogs].
    Gerold M.
    Arzneimittelforschung; 1968 Sep 15; 18(9):1198-200. PubMed ID: 5755936
    [No Abstract] [Full Text] [Related]

  • 27. Structural activity relationships of a series of amines injected before and after monoamine oxidase inhibitor.
    Gatgounis J.
    Arch Int Pharmacodyn Ther; 1965 Apr 15; 154(2):412-20. PubMed ID: 5838346
    [No Abstract] [Full Text] [Related]

  • 28. SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
    Aubin N, Barneoud P, Carter C, Caille D, Sontag N, Marc C, Lolivier J, Gardes A, Perron C, Le Kim A, Charieras T, Pandini M, Burnier P, Puech F, Jegham S, George P, Scatton B, Curet O.
    J Pharmacol Exp Ther; 2004 Sep 15; 310(3):1171-82. PubMed ID: 15178694
    [Abstract] [Full Text] [Related]

  • 29. Antihypertensive and monoamine oxidase inhibitory activity of 3-amino-2-oxazolidinone (3AO) and its condensation product with 2-substituted-3-formyl-4-oxo-(4H) pyrido(1,2-a)pyrimidines.
    Kaul CL, Grewal RS.
    Biochem Pharmacol; 1972 Feb 01; 21(3):303-16. PubMed ID: 5014489
    [No Abstract] [Full Text] [Related]

  • 30. Modification of blood pressure and nictitating membrane response to sympathetic amines by selective monoamine oxidase inhibitors, types A and B, in the cat.
    Finberg JP, Youdim MB.
    Br J Pharmacol; 1985 Jun 01; 85(2):541-6. PubMed ID: 3928010
    [Abstract] [Full Text] [Related]

  • 31. Cardiovascular changes in response to selective monoamine oxidase inhibition in the rat.
    Cohen RM, Campbell IC, Yamaguchi I, Pickar D, Kopin IJ, Murphy DL.
    Eur J Pharmacol; 1982 May 07; 80(1):155-60. PubMed ID: 6284529
    [Abstract] [Full Text] [Related]

  • 32. Effects of caroxazone, a reversible monoamine oxidase inhibitor, on the pressor response to oral tyramine in man.
    Martini A, Bonollo L, Nicolis FB, Sega R, Palermo A.
    Br J Clin Pharmacol; 1981 Jun 07; 11(6):611-5. PubMed ID: 7272178
    [Abstract] [Full Text] [Related]

  • 33. Pressor effect of oral tyramine during treatment with befloxatone, a new reversible monoamine oxidase-A inhibitor, in healthy subjects.
    Patat A, Berlin I, Durrieu G, Armand P, Fitoussi S, Molinier P, Caille P.
    J Clin Pharmacol; 1995 Jun 07; 35(6):633-43. PubMed ID: 7665725
    [Abstract] [Full Text] [Related]

  • 34. [SENSITIVITY OF LIVER MONOAMINE OXIDASE IN THE LAMPREY LAMPETRA FLUVIATILIS TO SOME TRICYCLIC COMPOUNDS].
    Basova LN, Basova NE, Suvorov AA, Yagodina OV.
    Zh Evol Biokhim Fiziol; 2015 Jun 07; 51(3):163-9. PubMed ID: 26281218
    [Abstract] [Full Text] [Related]

  • 35. Selective pressor enhancement by monoamine oxidase inhibitors in conscious rats.
    Kerecsen L, Bunag RD.
    J Pharmacol Exp Ther; 1989 Nov 07; 251(2):645-9. PubMed ID: 2509682
    [Abstract] [Full Text] [Related]

  • 36. Interaction of moclobemide and tricyclic antidepressants with the tyramine pressor effect in rats.
    Burkard W, d'Agostini F, Kettler R, Da Prada M.
    Psychopharmacology (Berl); 1992 Nov 07; 106 Suppl():S35-6. PubMed ID: 1546137
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation.
    Youdim MB, Weinstock M.
    Neurotoxicology; 2004 Jan 07; 25(1-2):243-50. PubMed ID: 14697899
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.